12 нояб. 2011 г. · The objective of this study is to examine the independent effects of ACE inhibitor and ARB on bone loss in older men.

They concluded that lisinopril may have therapeutic potential in the treatment of osteoporosis. A clinical trial investigated the effect of lisinopril on bone ...

Users of angiotensin-converting enzyme (ACE) inhibitors had a small but significant increase in bone loss at the hip over 4 years after adjustment for ...

10 июл. 2009 г. · A recent analysis of clinical studies suggests that angiotensin-converting enzyme (ACE) inhibitors might reduce bone fractures.

21 нояб. 2016 г. · Chlorthalidone use was associated with a significantly lower risk of fracture compared with lisinopril use (HR, 0.75; 95% CI, 0.58-0.98; P = .

7 мая 2014 г. · The association between long-term use of ARBs and ACE inhibitors and fracture requiring medical attention is limited.

14 июл. 2022 г. · This study investigated fracture risk for users of angiotensin converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB).

28 февр. 2017 г. · Chlorthalidone was associated with a 21 percent lower risk of hip and pelvic fractures, compared with the other two drugs.

7 сент. 2023 г. · Numerous animal experiments and clinical studies have shown that ACE inhibitors reduce bone loss, improve BMD, increase bone biomechanical ...

The effect of the drug was accompanied by low levels of granulation tissue and osteomalacia, as well as high levels of angiogenesis. Overall, bone regeneration ...